SCI Abstract

search
Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Effect of statin use on liver enzymes and lipid profile in patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
BACKGROUNDNon-alcoholic fatty liver disease (NAFLD) is an independent risk factor for cardiovascular disease (CVD). Statin...
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic
Patients attending vascular or diabetic foot clinics commonly have atherosclerotic disease, are at increased risk of cardi...
The role of genetically-influenced phospholipid transfer protein activity in lipoprotein metabolism and coronary artery disease
The role of genetically-influenced phospholipid transfer protein activity in lipoprotein metabolism and coronary artery disease
BACKGROUNDPhospholipid transfer protein (PLTP) transfers surface phospholipids between lipoproteins and as such plays a ro...
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice
Available online 1 April 2024Author links open overlay panel, , , , , , , , , , , , , , Highlights•Lp(a) level should be m...
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: ODYSSEY OUTCOMES
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: ODYSSEY OUTCOMES
Available online 10 April 2024Author links open overlay panel, , , , , , , , , , , , , , , , Highlights•Alirocumab improve...
Unfavorably altered lipid profile in women with primary ovarian insufficiency
Unfavorably altered lipid profile in women with primary ovarian insufficiency
Premature ovarian insufficiency (POI) is defined as the cessation of ovarian function before the age of 40 along with elev...
Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)
Discrimination and net-reclassification of cardiovascular disease risk with Lipoprotein(a) levels: The ATTICA study (2002–2022)
Numerous studies have confirmed that lipoproteins containing apolipoprotein B (apoB), such as low-density lipoproteins (LD...
Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening
Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening
Heterozygous Familial Hypercholesterolemia (HeFH) is an autosomal dominant genetic disorder that affects approximately 1 i...
Overcoming barriers to implementation: Improving incidental coronary calcium reporting on non-EKG gated chest CT scans
Overcoming barriers to implementation: Improving incidental coronary calcium reporting on non-EKG gated chest CT scans
The 2018 AHA/ACC Multisociety Blood Cholesterol Guideline1 states that the use of coronary artery calcium (CAC) scoring is...
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population
Abetalipoproteinemia (ABL) is a rare monogenic familial hypobetalipoproteinemia disorder characterized by a secretion defe...
Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation
Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation
Available online 27 April 2024Author links open overlay panel, , , , , , Highlights•Elevated lipoprotein(a) is an establis...
Hepatic Fat Changes with Antisense Oligonucleotide Therapy Targeting ANGPTL3
Hepatic Fat Changes with Antisense Oligonucleotide Therapy Targeting ANGPTL3
A.Z, S.D.W, J.G.P, S.A.M., X.R., A.J., J.F.K., M.S.S., B.A.B., and N.A.M. are members of the TIMI Study Group, which has r...
Universal Lipid Screening in Adolescents to Identify Familial Hypercholesterolemia in a Large Healthcare System
Universal Lipid Screening in Adolescents to Identify Familial Hypercholesterolemia in a Large Healthcare System
Familial Hypercholesterolemia (FH) is a common treatable monogenic disorder found throughout the world with an estimated p...
A Case Report Of Tangier Disease Presents With Acute Sensorimotor Polyneuropathy And Its Treatment Approach
A Case Report Of Tangier Disease Presents With Acute Sensorimotor Polyneuropathy And Its Treatment Approach
Available online 2 December 2023Author links open overlay panel, , , , ABSTRACTPolyneuropathy is a frequently encountered ...
Differential Impacts of Admission LDL-Cholesterol on Early Vascular Outcomes by Ischemic Stroke Subtypes
Differential Impacts of Admission LDL-Cholesterol on Early Vascular Outcomes by Ischemic Stroke Subtypes
The etiology of ischemic stroke is heterogeneous and can be categorized into five subtypes based on potential mechanisms: ...
Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study
Lipoprotein(a) levels and carotid intima-media thickness in children: A 20-year follow-up study
Elevated lipoprotein(a) [Lp(a)] levels are associated with an increased risk of cardiovascular disease (CVD)1,2. With a re...
Habitual fish oil supplementation, genetic susceptibility of kidney stones and the risk of new-onset kidney stones
Habitual fish oil supplementation, genetic susceptibility of kidney stones and the risk of new-onset kidney stones
Kidney stones are a common, costly, and painful disease, affecting about 10% of adults worldwide, with the prevalence and ...
Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis
Fatty acid analysis in serum of patients with elevated lipoprotein(a) and cardiovascular disease undergoing lipoprotein apheresis
Available online 28 November 2023Author links open overlay panel, , , , , , , , Highlights•Serum VLCFAs and VLC-MUFAs were...
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial Hypercholesterolaemia
Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial Hypercholesterolaemia
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia
Genetic risk score in patients with the APOE2/E2 genotype as a predictor of familial dysbetalipoproteinemia
Cardiovascular diseases (CVDs), mainly atherosclerotic diseases (ASCVDs), remain the leading cause of premature morbidity ...
Comparison of Virtual vs Face-to-face Medical Nutrition Therapy in Patients with Hyperlipidemia
Comparison of Virtual vs Face-to-face Medical Nutrition Therapy in Patients with Hyperlipidemia
Cardiovascular disease (CVD) is the leading cause of death in the United States,1 and the greatest contributor is poor nut...